Your institution may have access to this item. Find your institution then sign in to continue.
Title
Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Authors
Jean, G; Terrat, J C; Vanel, T; Hurot, J M; Lorriaux, C; Mayor, B; Chazot, C
Abstract
End-stage renal disease (ESRD) patients are thought to have impaired 1-alpha-hydroxylase capacity, but an extrarenal source of 1,25(OH)(2)D has been recognized.